Independent Director · GoodRx Holdings, Inc. (GDRX)

Chair, Nominating/Governance Committee

Christopher Adams director compensation at GoodRx (FY2025): $0

Fiscal year 2025 director compensation for Christopher Adams at GoodRx Holdings, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 29, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Christopher Adams’s full pay file as a PDF — free

More than this page: up to 10 years of Christopher’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Christopher Adams and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

GoodRx Director Compensation Table · all 5 fiscal years held
In US dollars, as GoodRx reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$0$0$0$0$0
FY2024$0$0$0$0—
FY2023$0$0$0$0—
FY2022$0$0$0$0—
FY2021$0$0$0—$0

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GoodRx Holdings, Inc. DEF 14A filed April 29, 2026, accession 0001809519-26-000091, and prior-year filings. Open the filing on EDGAR.

How this page was built: the GoodRx Holdings, Inc. filed document, accession 0001809519-26-000091. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.

Get the GoodRx Board Governance Report

$0 Christopher Adams, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 29, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

GoodRx pays directors a $30,000 cash retainer and $230,000 in RSUs.

Committees

FY2025 · as the proxy prints them

Compensation · Nominating/Governance (Chair)

The rest of the GoodRx board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Agnes Rey-GiraudIndependent Director$270,114
Douglas HirschDirector$254,777
Gregory MondreIndependent Director$0
Julie BradleyDirector—
Kelly J. KennedyIndependent Director$264,777
Ronald E. BruehlmanIndependent Director$274,777

The full GoodRx compensation record

free company brief

This page is one director within GoodRx's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the GoodRx proxy · each links to its own free brief

Order GDRX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report